UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Statin therapy and autoimmune disease: from protein prenylation to immunomodulation

Nature Reviews: Immunology, 2006-05, Vol.6 (5), p.358-370

2006

Link zum Volltext

Verfügbarkeit prüfen

Laquinimod, an up-and-coming immunomodulatory agent for treatment of multiple sclerosis

Experimental neurology, 2014-12, Vol.262, p.66-71

2014

Link zum Volltext

Verfügbarkeit prüfen

Laquinimod, a quinoline-3-carboxamide, induces type II myeloid cells that modulate central nervous system autoimmunity

PloS one, 2012-03, Vol.7 (3), p.e33797-e33797

2012

Link zum Volltext

Verfügbarkeit prüfen

K+ channel alterations in the progression of experimental autoimmune encephalomyelitis

Neurobiology of disease, 2012-08, Vol.47 (2), p.280-293

2012

Link zum Volltext

Verfügbarkeit prüfen

SAkuraBONSAI: Protocol design of a novel, prospective study to explore clinical, imaging, and biomarker outcomes in patients with AQP4-IgG-seropositive neuromyelitis optica spectrum disorder receiving open-label satralizumab

Frontiers in neurology, 2023-02, Vol.14, p.1114667-1114667

2023

Link zum Volltext

Verfügbarkeit prüfen

Switching multiple sclerosis patients with breakthrough disease to second-line therapy

PloS one, 2011-02, Vol.6 (2), p.e16664-e16664

2011

Link zum Volltext

Verfügbarkeit prüfen

Immunodominant T cell determinants of aquaporin-4, the autoantigen associated with neuromyelitis optica

PloS one, 2010-11, Vol.5 (11), p.e15050-e15050

2010

Link zum Volltext

Verfügbarkeit prüfen

Repetitive pertussis toxin promotes development of regulatory T cells and prevents central nervous system autoimmune disease

PloS one, 2010-12, Vol.5 (12), p.e16009-e16009

2010

Link zum Volltext

Verfügbarkeit prüfen

Beginning of the end of two-stage theory purporting that inflammation then degeneration explains pathogenesis of progressive multiple sclerosis

Current opinion in neurology, 2016-06, Vol.29 (3), p.340-344

2016

Link zum Volltext

Verfügbarkeit prüfen

Lymph node-derived donor encephalitogenic CD4+ T cells in C57BL/6 mice adoptive transfer experimental autoimmune encephalomyelitis highly express GM-CSF and T-bet

Journal of neuroinflammation, 2011-06, Vol.8 (1), p.73-73, Article 73

2011

Link zum Volltext

Verfügbarkeit prüfen

B cells in multiple sclerosis: connecting the dots

Current opinion in immunology, 2011-12, Vol.23 (6), p.713-720

2011

Link zum Volltext

Verfügbarkeit prüfen

Combining statins with interferon beta in multiple sclerosis: think twice, it might not be all right

Lancet neurology, 2011-08, Vol.10 (8), p.672-673

2011

Link zum Volltext

Verfügbarkeit prüfen

Statins as potential therapeutic agents in neuroinflammatory disorders

Current opinion in neurology, 2003-06, Vol.16 (3), p.393-401

2003

Link zum Volltext

Verfügbarkeit prüfen

Bench to Bedside Tempering antigen-presenting cells in multiple sclerosis

Nature medicine, 2008-06, Vol.14 (6), p.614-615

2008

Link zum Volltext

Verfügbarkeit prüfen

Laquinimod prevents disability progression in a model of spontaneous chronic EAE and interferes with development of follicular helper T cells

Journal of neuroimmunology, 2014-01, Vol.275 (1), p.209-209

2014

Link zum Volltext

Verfügbarkeit prüfen

Combination therapies for multiple sclerosis: scientific rationale, clinical trials, and clinical practice

Current opinion in neurology, 2007-06, Vol.20 (3), p.281-285

2007

Link zum Volltext

Verfügbarkeit prüfen

Myelin-specific antibodies trigger spontaneous CNS autoimmune disease in the absence of myelin-specific B cells

Journal of neuroimmunology, 2014-01, Vol.275 (1), p.7-8

2014

Link zum Volltext

Verfügbarkeit prüfen

T effectors outfox T regulators in autoimmunity

Nature medicine, 2007-04, Vol.13 (4), p.411-413

2007

Link zum Volltext

Verfügbarkeit prüfen

Pathogenesis, diagnosis, and treatment of acute disseminated encephalomyelitis

Current opinion in neurology, 1999-08, Vol.12 (4), p.395-401

1999

Link zum Volltext

Verfügbarkeit prüfen

The Immunogenicity of Disease-Modifying Therapies for Multiple Sclerosis: Clinical Implications for Neurologists

The Neurologist (Baltimore, Md.), 2007-11, Vol.13 (6), p.355-362

2007

Link zum Volltext

Verfügbarkeit prüfen

Specific immunotherapy: One size does not fit all

Nature medicine, 2000-10, Vol.6 (10), p.1098-1100

2000

Link zum Volltext

Verfügbarkeit prüfen

Statins as potential therapeutic agents in neuroinflammatory disorders

Current opinion in neurology, 2003-06, Vol.16 (3), p.393-401

2003

Link zum Volltext

Verfügbarkeit prüfen

Pediatric NMOSD: A Review and Position Statement on Approach to Work-Up and Diagnosis

Frontiers in pediatrics, 2020-06, Vol.8, p.339-339

2020

Link zum Volltext

Verfügbarkeit prüfen

Approved and Future Pharmacotherapy for Multiple Sclerosis

The Neurologist (Baltimore, Md.), 2002-09, Vol.8 (5), p.290-301

2002

Link zum Volltext

Verfügbarkeit prüfen

Lymph node-derived donor encephalitogenic CD4.sup.+ .sup.T cells in C57BL/6 mice adoptive transfer experimental autoimmune encephalomyelitis highly express GM-CSF and T-bet

Journal of neuroinflammation, 2011-06, Vol.8, p.73

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 29

Suche als RSS-Feed

Aktive Filter

SpracheFranzösisch

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(20)
Life Sciences & Biomedicine
(16)
Humans
(14)
Animals
(12)
Multiple Sclerosis
(12)
Neurology
(11)
Neurosciences & Neurology
(11)
Neurosciences
(10)
Clinical Neurology
(7)
Multiple Sclerosis - Immunology
(7)
Allergy And Immunology
(6)
Autoimmune Diseases
(6)
Immunology
(6)
Mice
(6)
Mice, Inbred C57bl
(5)
Analysis
(4)
Encephalomyelitis, Autoimmune, Experimental - Immunology
(4)
Experimental Autoimmune Encephalomyelitis
(4)
Female
(4)
Immunomodulation
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Statin therapy and autoimmune disease: from protein prenylation to immunomodulation

Laquinimod, an up-and-coming immunomodulatory agent for treatment of multiple sclerosis

Laquinimod, a quinoline-3-carboxamide, induces type II myeloid cells that modulate central nervous system autoimmunity

K+ channel alterations in the progression of experimental autoimmune encephalomyelitis

SAkuraBONSAI: Protocol design of a novel, prospective study to explore clinical, imaging, and biomarker outcomes in patients with AQP4-IgG-seropositive neuromyelitis optica spectrum disorder receiving open-label satralizumab

Switching multiple sclerosis patients with breakthrough disease to second-line therapy

Immunodominant T cell determinants of aquaporin-4, the autoantigen associated with neuromyelitis optica

Repetitive pertussis toxin promotes development of regulatory T cells and prevents central nervous system autoimmune disease

Beginning of the end of two-stage theory purporting that inflammation then degeneration explains pathogenesis of progressive multiple sclerosis

Lymph node-derived donor encephalitogenic CD4+ T cells in C57BL/6 mice adoptive transfer experimental autoimmune encephalomyelitis highly express GM-CSF and T-bet

B cells in multiple sclerosis: connecting the dots

Combining statins with interferon beta in multiple sclerosis: think twice, it might not be all right

Statins as potential therapeutic agents in neuroinflammatory disorders

Bench to Bedside Tempering antigen-presenting cells in multiple sclerosis

Laquinimod prevents disability progression in a model of spontaneous chronic EAE and interferes with development of follicular helper T cells

Combination therapies for multiple sclerosis: scientific rationale, clinical trials, and clinical practice

Myelin-specific antibodies trigger spontaneous CNS autoimmune disease in the absence of myelin-specific B cells

T effectors outfox T regulators in autoimmunity

Pathogenesis, diagnosis, and treatment of acute disseminated encephalomyelitis

The Immunogenicity of Disease-Modifying Therapies for Multiple Sclerosis: Clinical Implications for Neurologists

Specific immunotherapy: One size does not fit all

Statins as potential therapeutic agents in neuroinflammatory disorders

Pediatric NMOSD: A Review and Position Statement on Approach to Work-Up and Diagnosis

Approved and Future Pharmacotherapy for Multiple Sclerosis

Lymph node-derived donor encephalitogenic CD4.sup.+ .sup.T cells in C57BL/6 mice adoptive transfer experimental autoimmune encephalomyelitis highly express GM-CSF and T-bet

Aktive Filter

Suchergebnisse filtern